This site is intended for health professionals only

Home / News / Pharmacists should be able to supply aspirin to pregnant women to prevent pre-eclampsia, says expert

Pharmacists should be able to supply aspirin to pregnant women to prevent pre-eclampsia, says expert


By Isabel Shaw
Reporter

22 May 2020

Allowing community pharmacists to supply low-dose aspirin to pregnant women who are at risk of pre-eclampsia could prevent the condition, an expert says.

National guidelines suggest that women at risk of developing the condition should begin to take a low dose of aspirin at 12 weeks of pregnancy, however over half of all women who are at risk are missing out on the treatment.

Pre-eclampsia affects up to 6% of pregnancies and is the leading cause of premature birth, restricted fetal growth and stillbirth.

In the Drug and Therapeutics Bulletin, Consultant obstetrician Dr Joanna Girling of West Middlesex University Hospital, London said that she believed the reason many women are not getting access to the treatment is because of concerns surrounding the safety of taking drugs during pregnancy and because midwives are not able to prescribe.

Midwives usually advise pregnant mothers to consult their GP, but getting an appointment can take considerable time and could mean some women miss out on getting the treatment when they need it, she added.

To help women get the access they need, Dr Girling believes community pharmacists should be allowed to supply low-dose aspirin to women who are at risk of pre-eclampsia.

This would mean women could be treated more easily and faster. It would work out cheaper for women, who may otherwise buy the ‘unnecessary branded pregnancy-related nutrients and supplements,’ she suggested.

However, as it stands, pharmacists are not allowed to supply pregnant women with low-dose aspirin.

‘If we are serious about increasing uptake of a nationally recommended, evidence-based, life-saving, low-cost intervention, how about developing a national [protocol] to allow community pharmacists to supply low-dose aspirin to women who are at risk of pre-eclampsia,’ Dr Girling suggested.


Want news like this straight to your inbox?


Latest News

Naloxone
Naloxone should be available in every community pharmacy in Scotland, says RPS
The Royal Pharmaceutical Society (RPS) in Scotland is calling for naloxone, which blocks the effects...
co-codamol
4,000 packs of co-codamol recalled over incorrect dosage concerns
Over 4,000 packs of co-codamol 30/500 effervescent tablets made by the manufacturer Zentiva Pharma UK...
Blood pressure medication
Covid causes new fluoxetine shortage
The antidepressant, fluoxetine (Olena) 20mg dispersible sugar free tablets, will be out of stock until...